<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>FORM 8-K</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>CURRENT REPORT</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B>Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934</B>&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">Date of Report (Date of earliest
event reported): February 7, 2012 (February 6, 2012)&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><U>Bluesphere Corporation</U></B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">(Exact name of Registrant as specified
in its Charter)</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font-family: Times New Roman, Times, Serif">
<TR>
    <TD STYLE="width: 33%; line-height: 115%; font-size: 10pt; text-align: center">&nbsp; <U>Nevada</U></TD>
    <TD STYLE="width: 34%; line-height: 115%; font-size: 10pt; text-align: center">&nbsp;<U>&nbsp;333-147716</U></TD>
    <TD STYLE="width: 33%; line-height: 115%; font-size: 10pt; text-align: center">&nbsp;<U>&nbsp;98-0550257</U></TD></TR>
<TR>
    <TD>
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">&nbsp; (State or Other Jurisdiction</P>
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">of Incorporation or Organization)</P></TD>
    <TD STYLE="vertical-align: top; line-height: 115%; font-size: 10pt; text-align: center">&nbsp; (Commission File Number)</TD>
    <TD STYLE="vertical-align: top">
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">&nbsp; (I.R.S. Employer Identification</P>
        <P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">No.)</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><B><U>35 Asuta St., P.O.B 857, Even
Yehuda, Israel 40500 </U></B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">(Address of Principal Executive
Offices)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(Zip Code)</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">Registrant's telephone number, including
area code: <B><U>972-9-8917438</U></B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><U>Not Applicable</U></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><FONT STYLE="font-size: 10pt; line-height: 115%">(Former
Name or Former Address, if Changed since Last Report)</FONT></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><FONT STYLE="font-family: Wingdings 2">&#163;</FONT>&nbsp;Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>Item 3.02 Unregistered Sales of Equity Securities.</B></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"><FONT STYLE="color: black">On February
6, 2012, Registrant issued and transferred to Mr. Joshua Shoham 2,000,000 shares of its common stock in exchange for Mr. Shoham&rsquo;s
upcoming service as a director of the Registrant for a term of two years. </FONT>Such stock will be subject to pro rata forfeiture
in the event that Mr. Shoham terminates his directorship prior to the second anniversary of such service.</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"><B>Item 5.02 - Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</B></P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">On February 6, 2012, Registrant&rsquo;s Board of Directors
approved the increase of the number of directors from two to three and the appointment of Mr. Joshua Shoham as the Registrant&rsquo;s
third director for a term of two years. Mr. Shoham will receive 2,000,000 shares of common stock in exchange for his service as
a director. Such stock will be subject to pro rata forfeiture in the event that Mr. Shoham terminates his directorship prior to
the second anniversary thereof.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0">Mr. Shoham has extensive experience in international business
development and management. He was general manager of a Fortune 100 international paper subsidiary in Israel, co-founder of several
Israeli high-tech startups and strategic market development consultant responsible for a range of transactions and investments.
Mr. Shoham worked intensively in global markets and has served for six years as a Director in Bio-Cell (TASE: BCEL), which reversed
merged its activities into Protalix Biotherapeutics Inc. (AMEX:PLX; TASE: PLX). Mr. Shoham holds an LL.B degree from Tel Aviv University
School of Law and a B.A in Economics and MBA from the Hebrew University of Jerusalem.</P>

<P STYLE="font: 10pt/normal Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt">Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereto duly authorized.</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2"><B>Bluesphere Corporation</B></TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Dated:&nbsp;&nbsp;February 7, 2012</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ Shlomo Palas</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">Shlomo Palas CEO<BR></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 2pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>

<P STYLE="font: 10pt/115% Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "v301620_8k.htm", "description": "8-K", "secsgml_size_bytes": 9853}]
{"company-data": {"conformed-name": "BLUE SPHERE CORP.", "cik": "0001419582", "assigned-sic": "7370", "irs-number": "980550257", "state-of-incorporation": "NV", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-147716", "film-number": "12578912"}, "business-address": {"street1": "35 ASUTA STREET, PO BOX 857", "city": "EVEN YEHUDA", "state": "L3", "zip": "40500", "phone": "972-9-8917438"}, "mail-address": {"street1": "35 ASUTA STREET, PO BOX 857", "city": "EVEN YEHUDA", "state": "L3", "zip": "40500"}, "former-company": [{"former-conformed-name": "Blue Sphere Corp", "date-changed": "20100219"}, {"former-conformed-name": "Jin Jie Corp.", "date-changed": "20071128"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): February 7, 2012 (February 6, 2012)
Bluesphere Corporation
(Exact name of Registrant as specified
in its Charter)
Nevada
333-147716
98-0550257
(State or Other Jurisdiction
of Incorporation or Organization)
(Commission File Number)
(I.R.S. Employer Identification
No.)
35 Asuta St., P.O.B 857, Even
Yehuda, Israel 40500
(Address of Principal Executive
Offices)            (Zip Code)
Registrant's telephone number, including
area code:
972-9-8917438
Not Applicable
(Former
Name or Former Address, if Changed since Last Report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General
Instruction A.2. below):
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
£
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
£
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
£
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 3.02 Unregistered Sales of Equity Securities.
On February
6, 2012, Registrant issued and transferred to Mr. Joshua Shoham 2,000,000 shares of its common stock in exchange for Mr. Shoham's
upcoming service as a director of the Registrant for a term of two years.
Such stock will be subject to pro rata forfeiture
in the event that Mr. Shoham terminates his directorship prior to the second anniversary of such service.
Item 5.02 - Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On February 6, 2012, Registrant's Board of Directors
approved the increase of the number of directors from two to three and the appointment of Mr. Joshua Shoham as the Registrant's
third director for a term of two years. Mr. Shoham will receive 2,000,000 shares of common stock in exchange for his service as
a director. Such stock will be subject to pro rata forfeiture in the event that Mr. Shoham terminates his directorship prior to
the second anniversary thereof.
Mr. Shoham has extensive experience in international business
development and management. He was general manager of a Fortune 100 international paper subsidiary in Israel, co-founder of several
Israeli high-tech startups and strategic market development consultant responsible for a range of transactions and investments.
Mr. Shoham worked intensively in global markets and has served for six years as a Director in Bio-Cell (TASE: BCEL), which reversed
merged its activities into Protalix Biotherapeutics Inc. (AMEX:PLX; TASE: PLX). Mr. Shoham holds an LL.B degree from Tel Aviv University
School of Law and a B.A in Economics and MBA from the Hebrew University of Jerusalem.
Pursuant to the requirements of the Securities Exchange
Act of 1934, the registrant has caused this report to be signed on its behalf by the undersigned hereto duly authorized.
Bluesphere Corporation
Dated:  February 7, 2012
By:
/s/ Shlomo Palas
Shlomo Palas CEO